959976-85-3

Upstream product

• 956325-23-8 tert-butyl ((1S,2S)-2-(hydroxymethyl)cyclohexyl)carbamate 
• 124-63-0 methanesulfonyl chloride 

Downstream Products

• 959977-01-6 tert-butyl N-[(1S,2R)-2-(cyanomethyl)cyclohexyl]carbamate 
• 1185732-57-3 tert-butyl N-[(1S,2R)-2-(azidomethyl)cyclohexyl]carbamate 

Relevant academic research and scientific papers

New compounds 966

Compounds of Formula I, or pharmaceutically acceptable salts thereof: wherein R2, R3, X, m and n are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are usef

MUSCARINIC RECEPTOR AGONISTS, COMPOSITIONS, METHODS OF TREATMENT THEREOF, AND PROCESSES FOR PREPARATION THEREOF 177

Compounds of Formula I, or pharmaceutically acceptable salts thereof: wherein Y, X, A, R1, R2, m, p, and q are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

NOVEL COMPOUNDS-300

Compounds of Formula I, or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4, m, n, q, s, t, X, and Y are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Novel Compounds

Compounds of Formulae I, or pharmaceutically acceptable salts thereof: wherein A1, A2, G1, G2 G3, R1, R2, X, Y, Z, m, n and p are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.